Identification of insulin-sensitizing molecules acting by disrupting the interaction between the Insulin Receptor and Grb14

Metabolic diseases are characterized by a decreased action of insulin. During the course of the disease, usual treatments frequently fail and patients are finally submitted to insulinotherapy. There is thus a need for innovative therapeutic strategies to improve insulin action. Growth factor recepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Gondoin, Anaïs, Hampe, Cornelia, Eudes, Richard, Fayolle, Cyril, Pierre-Eugène, Cécile, Miteva, Maria, Villoutreix, Bruno O., Charnay-Pouget, Florence, Aitken, David J., Issad, Tarik, Burnol, Anne-Françoise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715071/
https://www.ncbi.nlm.nih.gov/pubmed/29203791
http://dx.doi.org/10.1038/s41598-017-17122-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715071/
https://www.ncbi.nlm.nih.gov/pubmed/29203791
http://dx.doi.org/10.1038/s41598-017-17122-6

Ejemplares similares